• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 96 of 100
IL: Corporations In Illinois
FinanceHospira hit with further FDA scrutiny after $17 billion Pfizer deal
By Laura LorenzettiApril 8, 2015
PA: Mylan Headquarters
FinanceMylan goes big with $29 billion offer to buy Perrigo
By Laura LorenzettiApril 8, 2015
Pneumococcus Vaccine
Pfizer to stop selling vaccines in China after failing to get license renewal
By Reuters and Fortune EditorsApril 2, 2015
IL: Corporations In Illinois
FeaturesTakeda’s ready to shell out $2.2 billion to settle Actos drug cases
By Laura LorenzettiApril 1, 2015
FRANCE-HEALTH-ALLERGIES-POLLEN
RetailJ&J, Glaxo settle U.S. lawsuit over allergy ads
By ReutersMarch 30, 2015
First Day Of Trading For 2012 At The NYSE
FinanceDow gains 260 points as stock market jumps on news out of China
By Tom Huddleston Jr.March 30, 2015
Lincoln Continental To Be Phased Out
FeaturesGreece tries again and Ford brings back the Lincoln Continental — 5 things to know today
By Laura LorenzettiMarch 30, 2015
Walgreens workers no longer want you to ‘Be Well’
RetailWalgreens workers no longer want you to ‘Be Well’
By Ben GeierMarch 26, 2015
Where do CEOs with addictions go when they hit bottom?
LeadershipWhere do CEOs with addictions go when they hit bottom?
By Daniel BukszpanMarch 25, 2015
Merck
FeaturesMerck halts study in light of melanoma drug’s success
By Laura LorenzettiMarch 24, 2015
Logo of Swiss drugmaker Novartis is seen at its headquarters in Basel
FeaturesNovartis unit hit with $110 million gender discrimination suit
By ReutersMarch 17, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
FinanceValeant comes out a winner after upping its Salix bid to $11.1 billion
By Laura LorenzettiMarch 16, 2015
FRANCE-HEALTH-ALLERGIES-POLLEN
RetailSpring must be here! J&J sues Glaxo over allergy cure claims
By Geoffrey SmithMarch 13, 2015
Stefano Pessina, Executive Deputy Chairm
RetailIs Walgreens about to go shopping again?
By Reuters and Fortune EditorsMarch 12, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., speaks during their annual general meeting in Laval, Quebec
FinanceEndo International makes competing bid for Salix Pharmaceuticals
By ReutersMarch 11, 2015
1...
  • 94
  • 95
  • 96
  • 97
  • 98
...100
Most Popular
Success
After forcing workers back to the office, Goldman Sachs and JPMorgan Chase are now letting their staff work remotely—but only for the World Cupplaceholder alt text
By Orianna Rosa RoyleJune 23, 2026
Banking
Markets tumble worldwide as Fed resets expectations: $400 billion wiped off SpaceX stockplaceholder alt text
By Jim EdwardsJune 23, 2026
Personal Finance
Current price of oil as of June 23, 2026placeholder alt text
By Joseph HostetlerJune 23, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.